Paul E. Monahan, MD, is honored by National Hemophilia Foundation
Paul E. Monahan, MD, received the Leadership in Research Award from the National Hemophilia Foundation at NHF's 65th anniversary reception in New York City on June 12.
Paul E. Monahan, MD, received the Leadership in Research Award from the National Hemophilia Foundation at NHF's 65th anniversary reception in New York City on June 12.
Dr. Lim has been chosen as a recipient of the ASH Training Award for Fellows for the period July 1, 2013 - June 30, 2014. The title of her project is "'Contribution of erythrocytes to thrombin generation in sickle cell disease."
Members of the UNC Hemostasis/Thrombosis Group gave 21 oral presentations and presented five posters at the biannual meeting of the International Society on Thrombosis and Hemostasis in Amsterdam July 1-4, 2013.
Dr. Buckner was awarded the first Hemostasis and Thrombosis Research Society/Novo Nordisk Clinical Research Fellowship in Hemophilia and Rare Bleeding Disorders at the HTRS meeting held April 11-13, 2013 in Charlotte, NC.
In December 2012, the UNC Hemophilia Clinic began seeing adult patients with hemophilia and other bleeding disorders at Carolina Pointe II for routine clinic appointments.
The UNC TarHealers walker team raised $1,845 for Hemophilia of North Carolina, the state chapter of the National Hemophilia Foundation.
Information concerning the storage and use of temperature-sensitive biological products that have been involved in a temporary electrical power failure or flood conditions.
Clot Connect (clotconnect.org) is an outreach initiative of the Hemophilia and Thrombosis Center of the University of North Carolina at Chapel Hill. A report of the program’s most recent activities, utilization, funding and future plans is now available. View the March 2012 Clot Connect Program Report. About Clot Connect: Clot Connect‘s mission is to increase …
Raj Kasthuri, MD, is director of the new center of excellence for the treatment of hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, an inherited disorder of the blood vessels that can cause excessive bleeding.
The UNC Hemophilia and Thrombosis Center’s Blood Clot Outreach Program is the recipient of a grant from the North Carolina Cancer Hospital Endowment Fund to provide blood clot education to cancer patients. Cancer is a risk factor for developing blood clots in the veins, known as venous thromboembolism (VTE). Patients with cancer are four times …